Lasheaka McClellan

Lasheaka McClellan,

Assistant Director Of Hepatology Clinical Research

Department: MD-GASTROENTERLOGY-LIVER
Business Phone: (352) 273-7285

Grants

Feb 2024 ACTIVE
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Nonalcoholic Fatty Liver Disease (NAFLD)
Role: Other
Funding: SC LIVER RESEARCH CONSORTIUM via AKERO THERAPEUTICS
Jan 2024 ACTIVE
D419CR00035 LIVER-R An Observational Mult-Center Study to Evaluate Real-World Treatment Outcomes of Durvalumab-based Regimens in Hepatobiliary Cancers
Role: Other
Funding: ICON CLINICAL RESEARCH INC via ASTRAZENECA
Dec 2023 ACTIVE
Akero AK-US-001-0105 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
Role: Other
Funding: SC LIVER RESEARCH CONSORTIUM via AKERO THERAPEUTICS

Contact Details

Phones:
Business:
(352) 273-7285
Addresses:
Business Mailing:
PO Box 100272
GAINESVILLE FL 32610
Business Street:
Room 2258
2004 Mowry Road
GAINESVILLE FL 32610